Branched-chain amino acids and muscle ammonia detoxification in cirrhosis (Q38073719)

28 August 2017

1 reference

title

Branched-chain amino acids and muscle ammonia detoxification in cirrhosis (English)

1 reference

28 August 2017

4

Hendrik Vilstrup

1 reference

28 August 2017

Gitte Dam

1

1 reference

28 August 2017

Peter Ott

series ordinal

2

1 reference

28 August 2017

Niels Kristian Aagaard

series ordinal

3

1 reference

28 August 2017

15 January 2013

1 reference

28 August 2017

Metabolic Brain Disease

1 reference

28 August 2017

28

1 reference

28 August 2017

217-220

1 reference

28 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11011-013-9377-3

28 August 2017

0 references

cites work

Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Splanchnic and leg exchange of amino acids and ammonia in acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Oral branched-chain amino acids decrease whole-body proteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Three targets of branched-chain amino acid supplementation in the treatment of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Branched-chain amino acid oxidation by isolated rat tissue preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Muscle nitrogen metabolism in chronic hepatic insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9377-3

Uptake and metabolism of plasma glutamine by the small intestine

21 January 2018

1 reference

12 December 2020

Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle?

1 reference

12 December 2020

Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects

1 reference

12 December 2020

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis

1 reference

12 December 2020

Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis

1 reference

12 December 2020

Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma

1 reference

12 December 2020

[Amino acid metabolism in liver diseases]

1 reference

12 December 2020

Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group

1 reference

12 December 2020

Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication

1 reference

12 December 2020

The effect of normalization of plasma amino acids on hepatic encephalopathy in man

1 reference

12 December 2020

Altered clearance of free amino acids from plasma of patients with cirrhosis of the liver

1 reference

12 December 2020

Uptake of ammonia by muscle; its implications in ammoniagenic coma

1 reference

12 December 2020

10.1007/S11011-013-9377-3

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference